Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

Cited by (1,000)

Items 101–200 of 1,000

1. Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms
   Cheng-Len Sy, Pao‐Yu Chen, Chun-Wen Cheng, Ling-Ju Huang, Ching-Hsun Wang, Tu‐Hsuan Chang, Yi‐Chin Chang, Chia-Jung Chang, Ing-Moi Hii, Yu‐Lung Hsu et al. · 2022 · Journal of Microbiology Immunology and Infection
2. Association Between Colistin Dose and Microbiologic Outcomes in Patients With Multidrug-Resistant Gram-Negative Bacteremia
   Giulia Vicari, Seth R. Bauer, Elizabeth A. Neuner, Simon W. Lam · 2012 · Clinical Infectious Diseases
3. Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter Study
   Eilish McCann, Arjun Srinivasan, Charles Andrew DeRyke, Gang Ye, Daryl D. DePestel, John Murray, Vikas Gupta · 2018 · Open Forum Infectious Diseases
4. Bloodstream infections in the Intensive Care Unit
   Matteo Bassetti, Elda Righi, Alessia Carnelutti · 2016 · Virulence
5. Characteristics of and variation in airborne ARGs among urban hospitals and adjacent urban and suburban communities: A metagenomic approach
   Peng He, Yan Hong Wu, Wenzhong Huang, Xinwei Wu, Jiayun Lv, Pengda Liu, Li Bu, Zhijun Bai, Shouyi Chen, Wenru Feng et al. · 2020 · Environment International
6. Trends in Susceptibility of Escherichia coli from Intra-Abdominal Infections to Ertapenem and Comparators in the United States According to Data from the SMART Program, 2009 to 2013
   Sibylle H. Lob, Krystyna M. Kazmierczak, Robert E. Badal, Meredith Hackel, Samuel K. Bouchillon, Douglas J. Biedenbach, Daniel F. Sahm · 2015 · Antimicrobial Agents and Chemotherapy
7. Carbapenem-ResistantEnterobacteriaceae: A Strategic Roadmap for Infection Control
   N. Deborah Friedman, Yehuda Carmeli, Aaron Lea Walton, Mitchell J. Schwaber · 2017 · Infection Control and Hospital Epidemiology
8. Cumulative Effect of an Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle on Early Streamlining of Antimicrobial Therapy in Gram-Negative Bloodstream Infections
   Paul Brandon Bookstaver, Elizabeth Nimmich, T. J. Smith, Julie Ann Justo, Joseph E. Kohn, Katie Lynn Hammer, Casey Troficanto, Helmut Albrecht, Majdi N. Al‐Hasan · 2017 · Antimicrobial Agents and Chemotherapy
9. Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections
   Pierluigi Viale, Maddalena Giannella, Russell Edward Lewis, Emanuele Maria Trecarichi, Nicola Petrosillo, Mario Tumbarello · 2013 · Expert Review of Anti-infective Therapy
10. Carbapenem-Sparing Antibiotic Regimens for Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit
    Francesco Sbrana, Paolo Malacarne, Bruno Viaggi, S. Costanzo, P Léonetti, Alessandro Leonildi, Beatrice Casini, Carlo Tascini, Francesco Menichetti · 2012 · Clinical Infectious Diseases
11. Carbapenemase-producing Enterobacteriaceae: Risk factors for infection and impact of resistance on outcomes
    Shanthi Mariappan, Uma Sekar, Arunagiri Kamalanathan · 2017 · International Journal of Applied and Basic Medical Research
12. Carbapenemases: Partners in crime
    Karen Bush · 2013 · Journal of Global Antimicrobial Resistance
13. Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization
    Horrocks, Victoria, King, Olivia G., Yip, Alexander Y. G., Marques, Inês Melo, McDonald, Julie A. K. · 2023 · Microbiology
14. Mutations of the ompK36 Porin Gene and Promoter Impact Responses of Sequence Type 258, KPC-2-Producing Klebsiella pneumoniae Strains to Doripenem and Doripenem-Colistin
    Cornelius Joseph Clancy, Liang Chen, Jae Hoon Hong, Shaoji Cheng, Binghua Hao, Ryan K. Shields, Annie Farrell, Yohei Doi, Yanan Zhao, David S. Perlin et al. · 2013 · Antimicrobial Agents and Chemotherapy
15. Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality
    Lijun Tian, Ruoming Tan, Yang Chen, Jingyong Sun, Jialin Liu, Hongping Qu, Xiaoli Wang · 2016 · Antimicrobial Resistance and Infection Control
16. Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States
    Alice Y. Guh, Brandi M. Limbago, Alexander J. Kallen · 2014 · Expert Review of Anti-infective Therapy
17. Transfer from High-Acuity Long-Term Care Facilities Is Associated with Carriage of Klebsiella pneumoniae Carbapenemase–Producing Enterobacteriaceae: A Multihospital Study
    Kavitha K. Prabaker, Michael Y. Lin, Margaret McNally, Kartikeya Cherabuddi, Sana S Ahmed, Andrea Norris, Karen Lolans, Ruba M. Odeh, Vishnu V. Chundi, Robert A. Weinstein et al. · 2012 · Infection Control and Hospital Epidemiology
18. Genomic Surveillance Reveals Diversity of Multidrug-Resistant Organism Colonization and Infection: A Prospective Cohort Study in Liver Transplant Recipients
    Nenad Maćešić, Angela Gomez‐Simmonds, Sean B. Sullivan, Marla J. Giddins, Samantha A. N. Ferguson, Gautam Korakavi, David S Sanders Clare M Leeds, Sarah E. Park, Kevin Shim, Madeleine G. Sowash et al. · 2018 · Clinical Infectious Diseases
19. New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections
    Matteo Bassetti, Elda Righi · 2015 · Current Opinion in Critical Care
20. Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniae
    Mario Tumbarello, Enrico Maria Trecarichi, Fabio Tumietto, Valerio Del Bono, Francesco Giuseppe De Rosa, Matteo Bassetti, Angela Raffaella Losito, Sara Tedeschi, Carolina Saffioti, Silvia Corcione et al. · 2014 · Antimicrobial Agents and Chemotherapy
21. The Genomic Basis of Intrinsic and Acquired Antibiotic Resistance in the Genus Serratia
    Luisa Sandner-Miranda, Pablo Vinuesa, Alejandro Cravioto, Rosario Morales-Espinosa · 2018 · Frontiers in Microbiology
22. Activity of biapenem (RPX2003) combined with the boronate -lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae
    David M. Livermore, Shazad Mushtaq · 2013 · Journal of Antimicrobial Chemotherapy
23. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection
    Weiyang Lou, Shrinivas Venkataraman, Guansheng Zhong, Bisha Ding, Jeremy P. K. Tan, Liang Xu, Weimin Fan, Yi Yan Yang · 2018 · Acta Biomaterialia
24. Antibacterial Properties of Graphene Oxide–Copper Oxide Nanoparticle Nanocomposites
    Piumie Rajapaksha, Samuel Cheeseman, Stuart Hombsch, Billy James Murdoch, Sheeana Gangadoo, Ewan William Blanch, Yen Bach Truong, Daniel Cozzolino, Chris F. McConville, Russell J. Crawford et al. · 2019 · ACS Applied Bio Materials
25. Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial
    Ilana Oren, Hannah Sprecher, Renato Finkelstein, Salim Hadad, Ami Neuberger, Keatam Hussein, Ayelet Raz‐Pasteur, Noa Lavi, Elias Saad, Israel J. Henig et al. · 2013 · American Journal of Infection Control
26. Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak
    J.R. Paño‐Pardo, Guillermo Ruiz Carrascoso, Carolina Navarro-San Francisco, Rosa Gómez-Gil, Marta Mora-Rillo, María Pilar Romero‐Gómez, Natalia Fernández-Romero, Julio García‐Rodríguez, Verónica Pérez-Blanco, Francisco Moreno-Ramos et al. · 2012 · Journal of Antimicrobial Chemotherapy
27. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China
    Yuanyuan Li, Jihong Li, Tong Hu, Jia Hu, Ning Song, Yu Xin Zhang, Yuan Chen · 2020 · Antimicrobial Resistance and Infection Control
28. Transmission of carbapenem-resistant Enterobacteriaceae during ERCP: time to revisit the current reprocessing guidelines
    Zachary L. Smith, Young S. Oh, Kia Saeian, Charles E. Edmiston, Abdul H. Khan, Benson T. Massey, Kulwinder S. Dua · 2015 · Gastrointestinal Endoscopy
29. Occurrence and persistence of carbapenemases genes in hospital and wastewater treatment plants and propagation in the receiving river
    Lorenzo Proia, Adriana Anzil, Carles Borrego, Marinella Farré, Marta Llorca, Josep Sanchís, Pierre Bogaerts, José Luís Balcázar, Pierre Servais · 2018 · Journal of Hazardous Materials
30. Conventional NK Cells Can Produce IL-22 and Promote Host Defense in Klebsiella pneumoniae Pneumonia
    Xin Xu, Ido D. Weiss, Hongwei H. Zhang, Satya P Singh, Thomas A. Wynn, Mark S. Wilson, Joshua Marion Farber · 2014 · The Journal of Immunology
31. Scientific Opinion on Carbapenem resistance in food animal ecosystems
    EFSA Panel on Biological Hazards (BIOHAZ) · 2013 · EFSA Journal
32. A Semi‐Synthetic Glycoconjugate Vaccine Candidate for Carbapenem‐Resistant Klebsiella pneumoniae
    Peter H. Seeberger, Claney L. Pereira, Naeem Khan, Guozhi Xiao, Elizabeth Diago‐Navarro, Katrin Reppe, Bastian Opitz, Bettina C. Fries, Martin Witzenrath · 2017 · Angewandte Chemie International Edition
33. The secondary resistome of multidrug-resistant Klebsiella pneumoniae
    Bimal Jana, Amy K. Cain, William T. Doerrler, Christine J. Boinett, Maria C. Fookes, Julian Parkhill, Luca Guardabassi · 2017 · Scientific Reports
34. Trends in Resistance to Carbapenems and Third-Generation Cephalosporins among Clinical Isolates of Klebsiella pneumoniae in the United States, 1999–2010
    Nikolay P. Braykov, Michael R. Eber, Eili Y. Klein, Daniel J. Morgan, Ramanan Laxminarayan · 2013 · Infection Control and Hospital Epidemiology
35. The Suf iron–sulfur cluster biosynthetic system is essential in Staphylococcus aureus, and decreased Suf function results in global metabolic defects and reduced survival in human neutrophils
    Roberts, Christina A., Al-Tameemi, Hassan M., Mashruwala, Ameya A., Rosario-Cruz, Zuelay, Chauhan, Unnati, Sause, William E., Torres, Victor J., Belden, William J., Boyd, Jeffrey M. · 2017 · Infection and Immunity
36. Multi-directional electrodeposited gold nanospikes for antibacterial surface applications
    Aaron James Elbourne, Victoria E. Coyle, Vi Khanh Truong, Ylias Mohammad Sabri, Ahmad Esmaielzadeh Kandjani, Suresh K. Bhargava, Elena Pavlovna Ivanova, Russell J. Crawford · 2018 · Nanoscale Advances
37. Complete Nucleotide Sequences of bla KPC-4 - and bla KPC-5 -Harboring IncN and IncX Plasmids from Klebsiella pneumoniae Strains Isolated in New Jersey
    Liang Chen, Kalyan D. Chavda, Henry S. Fraimow, José R. Mediavilla, Roberto Gustavo Melano, Michael R. Jacobs, Robert A. Bonomo, Barry N. Kreiswirth · 2012 · Antimicrobial Agents and Chemotherapy
38. Effects of KPC Variant and Porin Genotype on the In Vitro Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae
    William R. Wilson, Ellen G Kline, Chelsea E Jones, Kristin M. Morder, Roberta T. Mettus, Yohei Doi, M. Hong Nguyen, Cornelius Joseph Clancy, Ryan K. Shields · 2019 · Antimicrobial Agents and Chemotherapy
39. IMP-Producing Carbapenem-Resistant Klebsiella pneumoniae in the United States
    Brandi M. Limbago, James Kamile Rasheed, Karen F. Anderson, Wenming Zhu, Brandon Kitchel, Nancy Watz, Susan Munro, Hayley A. Gans, Niaz Banaei, Alex J. Kallen · 2011 · Journal of Clinical Microbiology
40. Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation
    Xuan Wang, Ying Wang, Xing Fan, Wei Tang, Jiong Hu · 2015 · Medicine
41. Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011
    Mirjam J. D. Dautzenberg, J M Ossewaarde, Marlieke E.A. de Kraker, Anneke van der Zee, Sebastian van Burgh, Sabine C. de Greeff, Henk A. Bijlmer, Hajo Grundmann, J.W. Cohen Stuart, Ad C. Fluit et al. · 2014 · Eurosurveillance
42. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae
    Andrea Rocker, Jake A. Lacey, Matthew J. Belousoff, Jonathan J. Wilksch, Richard A. Strugnell, Mark R. Davies, Trevor J. Lithgow · 2020 · mBio
43. Emergence of New Delhi metallo-β-lactamase type 1-producing Enterobacteriaceae and non-Enterobacteriaceae: global case detection and bacterial surveillance
    Greta Bushnell, Fanny S Mitrani-Gold, Linda M. Mundy · 2013 · International Journal of Infectious Diseases
44. Multiplex PCR for Rapid Detection of Genes Multiplex PCR for Rapid Detection of Genes Encoding Class A Carbapenemases
    Sang Sook Hong, Kyeongmi Kim, Ji Young Huh, Bochan Jung, Myung Seo Kang, Yunsop Chong · 2012 · Annals of Laboratory Medicine
45. An overview of carbapenem-resistant organisms from food-producing animals, seafood, aquaculture, companion animals, and wildlife
    Flor Y. Ramírez-Castillo, Alma L. Guerrero-Barrera, Francisco Javier Avelar-González · 2023 · Frontiers in Veterinary Science
46. Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors
    Anou Moise Somboro, John Osei Sekyere, Daniel Gyamfi Amoako, Sabiha Y. Essack, Linda Antoinette Bester · 2018 · Applied and Environmental Microbiology
47. Increasing Prevalence of ESBL-Producing Multidrug Resistance Escherichia coli From Diseased Pets in Beijing, China From 2012 to 2017
    Yanyun Chen, Zhihai Liu, Yaru Zhang, Zhenbiao Zhang, Lei Lei, Zhaofei Xia · 2019 · Frontiers in Microbiology
48. Rectal Screening for Klebsiella pneumoniae Carbapenemases: Comparison of Real-Time PCR and Culture Using Two Selective Screening Agar Plates
    Kamaljit S Singh, Kathy A. Mangold, Kody Wyant, Donna M. Schora, Barbara Voss, Karen Lynn Kaul, Mary K. Hayden, Vishnu V. Chundi, Lance R. Peterson · 2012 · Journal of Clinical Microbiology
49. Harnessing CRISPR Effectors for Infectious Disease Diagnostics
    Roby P. Bhattacharyya, Sri Gowtham Thakku, Deborah Tan Hung · 2018 · ACS Infectious Diseases
50. Extraintestinal Foodborne Pathogens
    Lee W. Riley · 2020 · Annual Review of Food Science and Technology
51. Carbapenemase-producing enterobacteriaceae recovered from a Spanish river ecosystem
    Núria Piedra-Carrasco, Anna Fàbrega, William Calero‐Cáceres, Thais Cornejo-Sánchez, Maryury Brown-Jaque, Alba Mir-Cros, Maite Muniesa, Juan José González‐López · 2017 · PLoS ONE
52. Mechanism for carbapenem resistance of clinical Enterobacteriaceae isolates
    Yafei Ye, Lijuan Xu, Yanping Han, Zhe Chen, Cailin Liu, Liang Ming · 2017 · Experimental and Therapeutic Medicine
53. Chloramphenicol Resurrected: A Journey from Antibiotic Resistance in Eye Infections to Biofilm and Ocular Microbiota
    Lorenzo Drago · 2019 · Microorganisms
54. Isolation and plasmid characterization of carbapenemase (IMP-4) producing Salmonella enterica Typhimurium from cats
    Sam Abraham, Mark A. O’Dea, Darren John Trott, Rebecca Jane Abraham, David Hughes, Stanley Pang, Genevieve L. McKew, Elaine Y. L. Cheong, John Merlino, Sugiyono Saputra et al. · 2016 · Scientific Reports
55. Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections
    Jordan R. Smith, Jeffrey M. Rybak, Kimberly C. Claeys · 2020 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
56. Secrets of the Hospital Underbelly: Patterns of Abundance of Antimicrobial Resistance Genes in Hospital Wastewater Vary by Specific Antimicrobial and Bacterial Family
    Meghan Rose Perry, Hannah C. Lepper, Luke McNally, Bryan A. Wee, Patrick Munk, Amanda Warr, Barbara Moore, Pota Kalima, Carol Philip, Ana Maria de Roda Husman et al. · 2021 · Frontiers in Microbiology
57. Carbapenem-Resistant Enterobacteriaceae Infections in Children
    Kathleen Chiotos, Jennifer Han, Pranita D. Tamma · 2015 · Current Infectious Disease Reports
58. Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011–2016) case-control study
    Luigi Segagni Lusignani, Elisabeth Presterl, Beata Zatorska, Miriam Van den Nest, Magda Diab‐Elschahawi · 2020 · Antimicrobial Resistance and Infection Control
59. Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides—A Review
    András Fodor, Birhan Addisie Abate, Péter Deák, László Fodor, Ervin Gyenge, Michael Gardner Klein, Zsuzsanna Koncz–Kálmán, Josephat Muvevi, Laszlo Jr Otvos, Gyöngyi Székely et al. · 2020 · Pathogens
60. A Multidisciplinary Intervention to Reduce Infections of ESBL- and AmpC-Producing, Gram-Negative Bacteria at a University Hospital
    Jenny Dahl Knudsen, Stig Ejdrup Andersen, for the Bispebjerg Intervention Group · 2014 · PLoS ONE
61. Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial
    Patrick N. A. Harris, Anton Yariv Peleg, Jonathan R. Iredell, Paul Robert Ingram, Spiros Miyakis, Andrew James Stewardson, Benjamin A. Rogers, Emma Sue McBryde, Jason Alexander Roberts, Jeffrey Lipman et al. · 2015 · Trials
62. Bloodstream Infections Caused by Carbapenem-Resistant Enterobacterales: Risk Factors for Mortality, Antimicrobial Therapy and Treatment Outcomes from a Prospective Multicenter Study
    Chaoe Zhou, Longyang Jin, Qi Wang, Xiaojuan Wang, Fengning Chen, Yue Gao, Chunjiang Zhao, Hongbin Chen, Bin Cao, Hui Wang · 2021 · Infection and Drug Resistance
63. EPIDEMIOLOGY OF CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE INFECTIONS IN MEDITERRANEAN COUNTRIES
    Corrado Girmenia, Martina Canichella, Alessandra Serrao · 2016 · Mediterranean Journal of Hematology and Infectious Diseases
64. Phenotypic and Genotypic Characterization ofEnterobacteriaceaeProducing Oxacillinase-48–Like Carbapenemases, United States
    Joseph D. Lutgring, Wenming Zhu, Tom J. B. de Man, Johannetsy J. Avillan, Karen F. Anderson, David R. Lonsway, Lori A. Rowe, Dhwani Govil Batra, James Kamile Rasheed, Brandi M. Limbago · 2018 · Emerging infectious diseases
65. Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care
    Theodoros Karampatakis, Katerina Tsergouli, Εlias Iosifidis, Charalampos Antachopoulos, Areti Karapanagiotou, Aggeliki Karyoti, N. Gritsi-Gerogianni, Athanasios Tsakris, Emmanuel Roilides · 2018 · Journal of Hospital Infection
66. Evaluation of NG-Test Carba 5 for Rapid Phenotypic Detection and Differentiation of Five Common Carbapenemase Families: Results of a Multicenter Clinical Evaluation
    Stephen G. Jenkins, Nathan A. Ledeboer, Lars F. Westblade, Carey‐Ann D. Burnham, Matthew L. Faron, Yehudit Bergman, Rebecca Yee, Brian Mesich, Derek Gerstbrein, Meghan A. Wallace et al. · 2020 · Journal of Clinical Microbiology
67. Oral Gentamicin Gut Decontamination for Prevention of KPC-Producing Klebsiella pneumoniae Infections: Relevance of Concomitant Systemic Antibiotic Therapy
    Carlo Tascini, Francesco Sbrana, Sarah Flammini, Enrico Tagliaferri, Fabio Arena, Alessandro Leonildi, Ilaria Ciullo, Francesco Amadori, Antonello Di Paolo, Andrea Ripoli et al. · 2014 · Antimicrobial Agents and Chemotherapy
68. Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: a unique challenge in the era of untreatable infections
    Jorgelina de Sanctis, Luciléia Teixeira, David van Duin, Camila D. Odio, Geraldine S. Hall, J. Walton Tomford, Federico Pérez, Susan D. Rudin, Robert A. Bonomo, Wael K. Barsoum et al. · 2014 · International Journal of Infectious Diseases
69. Reversion of antibiotic resistance in multidrug-resistant pathogens using non-antibiotic pharmaceutical benzydamine
    Yuan Liu, Ziwen Tong, Jingru Shi, Tian Deng, Ruichao Li, Xia Xiao, Zhiqiang Wang · 2021 · Communications Biology
70. Genetic Diversity of Carbapenem-Resistant Enterobacteriaceae (CRE) Clinical Isolates From a Tertiary Hospital in Eastern China
    Minhui Miao, Huiyan Wen, Ping Xu, Siqiang Niu, Jingnan Lv, Xiaofang Xie, José R. Mediavilla, Yi-Wei Tang, Barry N. Kreiswirth, Xia Zhang et al. · 2019 · Frontiers in Microbiology
71. New Delhi Metallo-β-Lactamase-5–Producing Escherichia coli in Companion Animals, United States
    Stephen D. Cole, Laura Peak, Gregory H. Tyson, Renate Reimschuessel, Olgica Cerić, Shelley C. Rankin · 2020 · Emerging infectious diseases
72. Antimicrobial resistance and resistance mechanisms of Enterobacteriaceae in ICU and non-ICU wards in Europe and North America: SMART 2011–2013
    Sibylle H. Lob, Douglas J. Biedenbach, Robert E. Badal, Krystyna M. Kazmierczak, Daniel F Sahm · 2015 · Journal of Global Antimicrobial Resistance
73. Abundance of carbapenemase genes (blaKPC, blaNDM and blaOXA-48) in wastewater effluents from Tunisian hospitals
    Emna Nasri, Jéssica Subirats, Alexandre Sànchez-Melsió, Hédi Ben Mansour, Carles Borrego, José Luís Balcázar · 2017 · Environmental Pollution
74. Current methods for the identification of carbapenemases
    Abed Zahedi Bialvaei, Hossein Samadi Kafil, Mohammad Asgharzadeh, Mohammad Yousef Memar, Mehdi Yousefi · 2015 · Journal of Chemotherapy
75. Pediatric Carbapenem-resistant Enterobacteriaceae in Los Angeles, California, a High-prevalence Region in the United States
    Pia S. Pannaraj, Jennifer Dien Bard, Chiara Cerini, Scott J. Weissman · 2014 · The Pediatric Infectious Disease Journal
76. Management of Urinary Tract Infections in the Era of Increasing Antimicrobial Resistance
    Amanda Shepherd, Paul S. Pottinger · 2013 · Medical Clinics of North America
77. Next-Generation-Sequencing-Based Hospital Outbreak Investigation Yields Insight into Klebsiella aerogenes Population Structure and Determinants of Carbapenem Resistance and Pathogenicity
    Adel Malek, Kelly A. McGlynn, Samantha M. Taffner, Lynn Fine, Brenda L. Tesini, Jun Wang, Heba H. Mostafa, Sharon Petry, Archibald S. Perkins, PAUL S. GRAMAN et al. · 2019 · Antimicrobial Agents and Chemotherapy
78. Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010–2013)
    Helio Silva Sader, Mariana Castanheira, Robert K. Flamm, Rodrigo Elisandro Mendes, David J. Farrell, Ronald N. Jones · 2015 · Diagnostic Microbiology and Infectious Disease
79. Enterobacteriaceae producing the KPC-2 carbapenemase from hospital sewage
    Xinzhuo Zhang, Xiaojü Lu, Zhiyong Zong · 2012 · Diagnostic Microbiology and Infectious Disease
80. A Combined Disk Test for Direct Differentiation of Carbapenemase-Producing Enterobacteriaceae in Surveillance Rectal Swabs
    Spyros Pournaras, Olympia Zarkotou, Aggeliki Poulou, Ioulia Kristo, Georgia Vrioni, Katerina Themeli-Digalaki, Athanasios Tsakris · 2013 · Journal of Clinical Microbiology
81. Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand
    Thidarat Netikul, Pattarachai Kiratisin · 2015 · PLoS ONE
82. Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei
    Leah Wendy Roberts, Patrick N. A. Harris, Brian M. Forde, Nouri L. Ben Zakour, Elizabeth M. Catchpoole, Mitchell J. Stanton-Cook, Minh‐Duy Phan, Hanna Evelina Sidjabat, Haakon Bergh, Claire Heney et al. · 2020 · Nature Communications
83. A call for action
    Patrice Savard, Trish M. Perl · 2012 · Current Opinion in Infectious Diseases
84. Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature
    Nathaniel A. Cohen, Nitsan Maharshak · 2017 · Digestive Diseases and Sciences
85. Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-ResistantEnterobacteriaceae
    Nora Chea, Sandra N. Bulens, Thiphasone Kongphet-Tran, Ruth Lynfield, Kristin M. Shaw, Paula Snippes Vagnone, Marion A. Kainer, Daniel B. Muleta, Lucy E Wilson, Elisabeth Vaeth et al. · 2015 · Emerging infectious diseases
86. Population Pharmacokinetics of Intravenous Polymyxin B from Clinical Samples
    Christine J. Kubin, Brian C. Nelson, Cristina M. Miglis, Marc H. Scheetz, Nathaniel J. Rhodes, Sean N. Avedissian, Serge Cremers, Michael T. Yin · 2018 · Antimicrobial Agents and Chemotherapy
87. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan
    Yuko Komatsu, Kei Kasahara, Takashi Inoue, Sang‐Tae Lee, Tetsuro Muratani, Hisakazu Yano, Tadaaki Kirita, Keiichi Mikasa · 2018 · PLoS ONE
88. Predictive Value of Prior Colonization and Antibiotic Use for Third-Generation Cephalosporin-Resistant Enterobacteriaceae Bacteremia in Patients With Sepsis
    Rottier, Wouter C., Bamberg, Yara R. P., Dorigo-Zetsma, J. Wendelien, van der Linden, Paul D., Ammerlaan, Heidi S. M., Bonten, Marc J. M. · 2015 · Clinical Infectious Diseases
89. Control of Simultaneous Outbreaks of Carbapenemase-Producing Enterobacteriaceae and Extensively Drug-ResistantAcinetobacter baumanniiInfection in an Intensive Care Unit Using Interventions Promoted in the Centers for Disease Control and Prevention 2012 Carbapenemase-Resistant Enterobacteriaceae Toolkit
    Kyle B. Enfield, Nujhat N. Huq, Megan F. Gosseling, Darla J. Low, Kevin C. Hazen, DENISE M. TONEY, Gavin Slitt, Heidi J. Zapata, Heather L. Cox, Jessica D. Lewis et al. · 2014 · Infection Control and Hospital Epidemiology
90. Prevalence of carbapenem resistant Enterobacteriaceae from a tertiary care hospital in Mumbai, India
    Pravin Kumar Nair · 2013 · Journal of Microbiology and Infectious Diseases
91. The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae , an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit
    Bruce Y. Lee, Sarah M. Bartsch, Kim F. Wong, James A. McKinnell, Rachel B. Slayton, Loren Gregory Miller, Chenghua Cao, Diane S. Kim, Alexander J. Kallen, John A. Jernigan et al. · 2016 · American Journal of Epidemiology
92. Development and transmission of antimicrobial resistance among Gram-negative bacteria in animals and their public health impact
    Shewli Mukerji, Mark A. O’Dea, MARY D. BARTON, Roy Neville Kirkwood, Terence Lee, Sam Abraham · 2017 · Essays in Biochemistry
93. Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017–2018)
    Sirigade Ruekit, Apichai Srijan, Oralak Serichantalergs, Katie R. Margulieux, Patrick McGann, Emma G. Mills, William Stribling, Theerasak Pimsawat, Rosarin Kormanee, Suthisak Nakornchai et al. · 2022 · BMC Infectious Diseases
94. Complete Sequence of a bla KPC-2 -Harboring IncFII K1 Plasmid from a Klebsiella pneumoniae Sequence Type 258 Strain
    Liang Chen, Kalyan D. Chavda, Roberto Gustavo Melano, Michael R. Jacobs, Michael H. Levi, Robert A. Bonomo, Barry N. Kreiswirth · 2013 · Antimicrobial Agents and Chemotherapy
95. Risk factors for nephrotoxicity onset associated with polymyxin B therapy
    Yanina Dubrovskaya, Nishant Prasad, Yuman Lee, Diana Esaian, Deborah A. Figueroa, Vincent H. Tam · 2015 · Journal of Antimicrobial Chemotherapy
96. Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations
    Hervé Dupont, Olivier Gaillot, Anne-Sophie Goetgheluck, Claire Plassart, Jean-Philippe Émond, Marion Lecuru, Nicolas Gaillard, Sarah Derdouri, Baptiste Lemaire, M Girard de Courtilles et al. · 2015 · Antimicrobial Agents and Chemotherapy
97. Healthcare-Associated Infections in Pediatric and Neonatal Intensive Care Units: Impact of Underlying Risk Factors and Antimicrobial Resistance on 30-Day Case-Fatality in Italy and Brazil
    Laura Folgori, Paola Bernaschi, Simone Piga, Michaela Carletti, Filippe Pirrone Cunha, Paulo Henrique Rodriguez Lara, Nicholas Cafieiro de Castro Peixoto, Bárbara Gomes Alves Guimarães, Mike Sharland, André Ricardo Araújo da Silva et al. · 2016 · Infection Control and Hospital Epidemiology
98. Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes
    Rajnikant Sharma, Saloni Patel, Cely Saad Abboud, John K. Diep, Neang S. Ly, Jason M. Pogue, Keith S. Kaye, Jian Li, Gauri G. Rao · 2016 · International Journal of Antimicrobial Agents
99. Evaluation of Resistance Mechanisms in Carbapenem-Resistant Enterobacteriaceae
    Naser Alizadeh, Mohammad Ahangarzadeh Rezaee, Hossein Samadi Kafil, Alka Hasani, Mohammad Hossein Soroush Barhaghi, Morteza Milani, Fatemeh Yeganeh Sefidan, Mohammad Yousef Memar, Aidin Lalehzadeh, Reza Ghotaslou · 2020 · Infection and Drug Resistance
100. Rapid Expansion of KPC-2-Producing Klebsiella pneumoniae Isolates in Two Texas Hospitals due to Clonal Spread of ST258 and ST307 Lineages
     Mariana Castanheira, Sarah E. Farrell, Audrey R. Wanger, Kenneth V. Rolston, Ronald N. Jones, Rodrigo Elisandro Mendes · 2013 · Microbial Drug Resistance